129 related articles for article (PubMed ID: 1907247)
21. Evidence of a glycemic threshold for the formation of pentosidine in diabetic dog lens but not in collagen.
Nagaraj RH; Kern TS; Sell DR; Fogarty J; Engerman RL; Monnier VM
Diabetes; 1996 May; 45(5):587-94. PubMed ID: 8621008
[TBL] [Abstract][Full Text] [Related]
22. Capillary basement membrane in retina, kidney, and muscle of diabetic dogs and galactosemic dogs and its response to 5 years aldose reductase inhibition.
Engerman RL; Kern TS; Garment MB
J Diabetes Complications; 1993; 7(4):241-5. PubMed ID: 8219367
[TBL] [Abstract][Full Text] [Related]
23. Effect of treating streptozotocin-induced diabetic rats with sorbinil, myo-inositol or aminoguanidine on endoneurial blood flow, motor nerve conduction velocity and vascular function of epineurial arterioles of the sciatic nerve.
Coppey LJ; Gellett JS; Davidson EP; Dunlap JA; Yorek MA
Int J Exp Diabetes Res; 2002; 3(1):21-36. PubMed ID: 11900277
[TBL] [Abstract][Full Text] [Related]
24. Aldose reductase activity and basement membrane thickening.
Frank RN
Metabolism; 1986 Apr; 35(4 Suppl 1):35-40. PubMed ID: 3083207
[TBL] [Abstract][Full Text] [Related]
25. Retinal capillaries: basement membrane thickening by galactosemia prevented with aldose reductase inhibitor.
Robison WG; Kador PF; Kinoshita JH
Science; 1983 Sep; 221(4616):1177-9. PubMed ID: 6612330
[TBL] [Abstract][Full Text] [Related]
26. The effects of aldose reductase inhibition on nerve sorbitol and myoinositol concentrations in diabetic and galactosemic rats.
Yue DK; Hanwell MA; Satchell PM; Handelsman DJ; Turtle JR
Metabolism; 1984 Dec; 33(12):1119-22. PubMed ID: 6438438
[TBL] [Abstract][Full Text] [Related]
27. Diabetic-like retinopathy: early and late intervention therapies in galactose-fed rats.
Robison WG; Jacot JL; Glover JP; Basso MD; Hohman TC
Invest Ophthalmol Vis Sci; 1998 Sep; 39(10):1933-41. PubMed ID: 9727416
[TBL] [Abstract][Full Text] [Related]
28. Galactose cataract prevention with sorbinil, an aldose reductase inhibitor: a light microscopic study.
Datiles M; Fukui H; Kuwabara T; Kinoshita JH
Invest Ophthalmol Vis Sci; 1982 Feb; 22(2):174-9. PubMed ID: 6799419
[TBL] [Abstract][Full Text] [Related]
29. Inhibition in rat of development of in utero galactose-induced cataract by an aldose reductase inhibitor--a light microscopic study.
Teshima R; Taura T; Okamura R
Jpn J Ophthalmol; 1991; 35(3):317-24. PubMed ID: 1770672
[TBL] [Abstract][Full Text] [Related]
30. The effect of sorbinil, an aldose reductase inhibitor, on aortic function in control and streptozotocin-induced diabetic rats.
Sellers DJ; Chess-Williams R
J Auton Pharmacol; 2000 Feb; 20(1):15-22. PubMed ID: 11048957
[TBL] [Abstract][Full Text] [Related]
31. The effects of streptozotocin-induced diabetes and aldose reductase inhibition with sorbinil, on left and right atrial function in the rat.
Sellers DJ; Chess-Williams R
J Pharm Pharmacol; 2000 Jun; 52(6):687-94. PubMed ID: 10875546
[TBL] [Abstract][Full Text] [Related]
32. Ultrastructural localization of blood-retinal barrier breakdown in diabetic and galactosemic rats.
Vinores SA; McGehee R; Lee A; Gadegbeku C; Campochiaro PA
J Histochem Cytochem; 1990 Sep; 38(9):1341-52. PubMed ID: 2117624
[TBL] [Abstract][Full Text] [Related]
33. Good glycaemic control reduces oxidation and glycation end-products in collagen of diabetic rats.
Odetti P; Traverso N; Cosso L; Noberasco G; Pronzato MA; Marinari UM
Diabetologia; 1996 Dec; 39(12):1440-7. PubMed ID: 8960824
[TBL] [Abstract][Full Text] [Related]
34. Galactose-induced retinal microangiopathy in rats.
Kern TS; Engerman RL
Invest Ophthalmol Vis Sci; 1995 Feb; 36(2):490-6. PubMed ID: 7843917
[TBL] [Abstract][Full Text] [Related]
35. The effect of aldose reductase inhibitors on glomerular prostaglandin production and urinary albumin excretion in experimental diabetes mellitus.
Chang WP; Dimitriadis E; Allen T; Dunlop ME; Cooper M; Larkins RG
Diabetologia; 1991 Apr; 34(4):225-31. PubMed ID: 1906023
[TBL] [Abstract][Full Text] [Related]
36. Reversal of stage-I sugar cataract by Sorbinil, an aldose reductase inhibitor.
Beyer-Mears A; Cruz E; Varagiannis E
Pharmacology; 1985; 31(2):88-96. PubMed ID: 3927328
[TBL] [Abstract][Full Text] [Related]
37. CP-45,634: a novel aldose reductase inhibitor that inhibits polyol pathway activity in diabetic and galactosemic rats.
Peterson MJ; Sarges R; Aldinger CE; MacDonald DP
Metabolism; 1979 Apr; 28(4 Suppl 1):456-61. PubMed ID: 122297
[TBL] [Abstract][Full Text] [Related]
38. Vascular filtration function in galactose-fed versus diabetic rats: the role of polyol pathway activity.
Pugliese G; Tilton RG; Speedy A; Chang K; Province MA; Kilo C; Williamson JR
Metabolism; 1990 Jul; 39(7):690-7. PubMed ID: 2114513
[TBL] [Abstract][Full Text] [Related]
39. Effects of aldose reductase inhibitor sorbinil on neuroaxonal dystrophy and levels of myo-inositol and sorbitol in sympathetic autonomic ganglia of streptozocin-induced diabetic rats.
Schmidt RE; Plurad SB; Sherman WR; Williamson JR; Tilton RG
Diabetes; 1989 May; 38(5):569-79. PubMed ID: 2497038
[TBL] [Abstract][Full Text] [Related]
40. Aldose reductase inhibition and retinopathy.
Robison WG
Diabetes; 1994 Feb; 43(2):337-9. PubMed ID: 8288059
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
